Author:
Alghamdi Saeed Ali,Aldahneen Mohammed Sadiq,Beitar Feras Salah,Dyab Nariman Ahmad,Afaneh Liyan Khaled,Almutairi Rawan Obaid,Almanneai Faisal Abdulaziz,Albalawi Khalid Salem Audah,Alghanmi Ali Mohammed Salem,Elfaham Shireen
Reference21 articles.
1. 1. Almuqati AL, Alluqmani MS, Balhareth SH, Alosaimi MA, Alosaimi MM, Alzughaibi AM, et al. Evaluation of Role of Family Physicians in Management and Diagnosis of Hypertension in Primary Health Care Centers: A Simple Literature Review. J Adv Pharm Educ Res. 2020;9(1):105-9.
2. 2. Sinuraya RK, Rianti A, Suwantika AA. Cost minimization of cardiovascular disease (CVD) drugs in primary healthcare centers in Bandung, Indonesia. J Adv Pharm Edu Res. 2021;10(1):63-9.
3. 3. Chrysant SG, Chrysant GS, Desai A. Current status of angiotensin receptor blockers for the treatment of cardiovascular diseases: focus on telmisartan. J Hum Hypertens. 2005;19(3):173-83. Available from: doi:10.1038/sj.jhh.1001808
4. 4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72. doi:10.1001/jama.289.19.2560.
5. 5. Marques-Vidal P, Tuomilehto J. Hypertension awareness, treatment and control in the community: is the ‘rule of halves’ still valid?. J Hum Hypertens. 1997;11(4):213-20. doi:10.1038/sj.jhh.1000426